Search research articles
Contact Us
Filters
Showing results (171-180 of 365) with videos related to
Page
of 37
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millennium
A S Levenson, V C Jordan
British Journal of Pharmacology
|
May 1, 1979
Control of experimental breast cancer by antioestrogenic therapies [proceedings]
C J Dix, V C Jordan
British Journal of Pharmacology
|
February 1, 1979
The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens
V C Jordan, K E Naylor
Cancer Research
|
May 15, 1998
The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor
A S Levenson, V C Jordan
British Journal of Pharmacology
|
January 1, 1980
Antioestrogenic derivatives of nafoxidine stimulate progesterone receptor synthesis in vivo [proceedings]
K E Allen, V C Jordan
British Journal of Pharmacology
|
January 1, 1980
Modulation of nuclear oestrogen receptor levels by oestrogen and antioestrogen [proceedings]
C J Dix, V C Jordan
The Journal of Steroid Biochemistry and Molecular Biology
|
December 1, 1994
Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines
A S Levenson, V C Jordan
The Journal of Endocrinology
|
February 1, 1976
Tamoxifen as an anti-tumour agent: effect on oestrogen binding
V C Jordan, L J Dowse
Drug Safety
|
May 1, 1993
A risk-benefit assessment of tamoxifen therapy
W H Catherino, V C Jordan
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
June 1, 1995
Gynecologic effects of tamoxifen and the association with endometrial carcinoma
V J Assikis, V C Jordan
Page
of 37
Search research articles
Search
Showing results (171-180 of 365) with videos related to
Sort By:
Page
of 37
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2000
Selective oestrogen receptor modulation: molecular pharmacology for the millennium
A S Levenson, V C Jordan
British Journal of Pharmacology
|
May 1, 1979
Control of experimental breast cancer by antioestrogenic therapies [proceedings]
C J Dix, V C Jordan
British Journal of Pharmacology
|
February 1, 1979
The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens
V C Jordan, K E Naylor
Cancer Research
|
May 15, 1998
The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor
A S Levenson, V C Jordan
British Journal of Pharmacology
|
January 1, 1980
Antioestrogenic derivatives of nafoxidine stimulate progesterone receptor synthesis in vivo [proceedings]
K E Allen, V C Jordan
British Journal of Pharmacology
|
January 1, 1980
Modulation of nuclear oestrogen receptor levels by oestrogen and antioestrogen [proceedings]
C J Dix, V C Jordan
The Journal of Steroid Biochemistry and Molecular Biology
|
December 1, 1994
Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines
A S Levenson, V C Jordan
The Journal of Endocrinology
|
February 1, 1976
Tamoxifen as an anti-tumour agent: effect on oestrogen binding
V C Jordan, L J Dowse
Drug Safety
|
May 1, 1993
A risk-benefit assessment of tamoxifen therapy
W H Catherino, V C Jordan
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
June 1, 1995
Gynecologic effects of tamoxifen and the association with endometrial carcinoma
V J Assikis, V C Jordan
Page
of 37